Publication | Open Access

QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial

Pulmonary TuberculosisRifampicin-resistant TuberculosisPharmacologyTuberculosisQt EffectsPharmacotherapyAntimicrobial ChemotherapyPhase 2MedicineAntimicrobial ResistanceDrug Resistance